|
|
|
|
| LEADER |
00000cam a22000003i 4500 |
| 001 |
EBOOKCENTRAL_ocn883573274 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
140708nuuuuuuuuxx ob 000 0 eng d |
| 040 |
|
|
|a COO
|b eng
|e pn
|c COO
|d EBLCP
|d OCLCQ
|d ZCU
|d MERUC
|d UUM
|d OCLCO
|d OCLCF
|d ICG
|d VT2
|d OCLCQ
|d DKC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 1280248041
|
| 020 |
|
|
|a 9781280248047
|
| 029 |
1 |
|
|a DEBBG
|b BV044108160
|
| 035 |
|
|
|a (OCoLC)883573274
|
| 050 |
|
4 |
|a RA644.A6.C4 2001eb
|
| 082 |
0 |
4 |
|a 616.956
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a CDC Anthrax Vaccine Safety & Efficacy Research Program :
|b Interim Report /
|c Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Board of the Medical Follow-Up Agency.
|
| 260 |
|
|
|a [Place of publication not identified] :
|b National Academies Press
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Title from content provider.
|
| 505 |
0 |
|
|a CDC Anthrax Vaccine Safety & Efficacy Research Program -- Copyright -- Contents -- Preface -- Acknowledgments -- REVIEWERS -- Executive Summary -- PROJECT-SPECIFIC FINDINGS AND RECOMMENDATIONS -- NCID-Directed Projects in the Research Program -- Human Clinical Trial, or Part A -- Animal dose ranging and challenge studies, or Part B -- Assays addressing correlates of immunity, or Part C -- Human Leukocyte Antigen (HLA) substudy -- NIP-Directed Projects of the Research Program
|
| 505 |
8 |
|
|a Survey of knowledge, attitudes, and beliefs of military personnel about the anthrax vaccineSurvey of knowledge, attitudes, and beliefs of military vaccinee providers about VAERS reporting -- CDC proposal for use of the Short Form 36 -- Remaining components of the research program directed by the NIP -- 1 Introduction and Background -- ANTHRAX DISEASE AND PREVENTION -- Anthrax Disease -- Anthrax Vaccine -- VACCINE RELATED ADVERSE EVENTS -- POLICY CONTEXT OF REPORT -- Anthrax Vaccination Policy -- CDC'S RESPONSE TO CONGRESS
|
| 505 |
8 |
|
|a 2 Interim Findings and Recommendations NCID RESEARCH ACTIVITIES -- Part A: Clinical Trial -- CDC proposal for use of the Short Form 36 -- Part B: Non-human Primate Dose-Ranging and Challenge Study -- Part C: Assays of Immunologic Correlates of Protection -- NIP RESEARCH ACTIVITIES -- Knowledge, Attitudes, and Beliefs of Military Personnel about the Anthrax Vaccine -- Knowledge, Attitudes, and Beliefs of Vaccine Providers about VAERS Reporting -- Data Mining Using the VAERS Database -- Meta-Analysis of Existing Studies on the Anthrax Vaccine -- REFERENCES
|
| 505 |
8 |
|
|a ACRONYMSAppendix A Study Activities -- Appendix B Biographical Sketches
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Anthrax
|x Vaccination.
|
| 650 |
|
0 |
|a Vaccines
|x Effectiveness.
|
| 650 |
|
0 |
|a Vaccines
|x Safety measures.
|
| 650 |
|
6 |
|a Vaccins
|x Efficacité.
|
| 650 |
|
6 |
|a Vaccins
|x Sécurité
|x Mesures.
|
| 650 |
|
7 |
|a Anthrax
|x Vaccination
|2 fast
|
| 650 |
|
7 |
|a Vaccines
|x Safety measures
|2 fast
|
| 710 |
1 |
|
|a Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Board of the Medical Follow-Up Agency.
|
| 710 |
1 |
|
|a Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program(CB)
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3377603
|z Texto completo
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3377603
|
| 994 |
|
|
|a 92
|b IZTAP
|
